Top
Begin typing your search above and press return to search.
exit_to_app
The virus of double standards
access_time 2021-04-17T12:13:23+05:30
The genocide in West Bengal
access_time 2021-04-13T11:08:29+05:30
A model mosque in Gujarat
access_time 2021-04-12T17:13:34+05:30
Revelations about the Rafale deal
access_time 2021-04-12T11:46:42+05:30
DEEP READ
A model mosque in Gujarat
access_time 2021-04-12T17:13:34+05:30
Towards a digital emergency?
access_time 2021-02-27T14:50:41+05:30
The slaughter of democracy in Puducherry
access_time 2021-02-24T11:27:21+05:30
Populist Fascism
access_time 2021-01-31T17:19:29+05:30
Media Freedom
access_time 2021-01-31T15:47:07+05:30
Sharjeel Imam
access_time 2021-01-30T15:19:40+05:30
exit_to_app
Homechevron_rightLifestylechevron_rightHealthchevron_rightCovid vaccine to be...

Covid vaccine to be available in the country by January: Serum Institute

text_fields
bookmark_border
Covid vaccine to be available in the country by January:  Serum Institute
cancel

In an interview with NDTV, Serum Institute of India (SII) CEO Adar Poonawalla announced that Covishield vaccine developed by Oxford-AstraZeneca is expected to be available in the country by January 2021. SII is in talks with the government for mass-production of the vaccine and if approved, around 100 million doses of the vaccine will be available by January, he added.

AstraZeneca earlier announced that Covishield has been proved 90 per cent effective without any side effects in tests conducted in England and Brazil.

"We are putting an MRP of Rs 1,000–for the private market and Rs 250 or less for the government," the Poonawalla told NDTV.

The vaccine will initially be available to one million health workers. The government aims to make around 300 to 400 million doses available by July.

Show Full Article
TAGS:Covid vaccine Serum institute 
Next Story